IDEAYA Biosciences Inc
NASDAQ:IDYA

Watchlist Manager
IDEAYA Biosciences Inc Logo
IDEAYA Biosciences Inc
NASDAQ:IDYA
Watchlist
Price: 35.2 USD -1.35%
Market Cap: 3.1B USD

Wall Street
Price Targets

IDYA Price Targets Summary
IDEAYA Biosciences Inc

Wall Street analysts forecast IDYA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDYA is 50.62 USD with a low forecast of 31.31 USD and a high forecast of 82.95 USD.

Lowest
Price Target
31.31 USD
11% Downside
Average
Price Target
50.62 USD
44% Upside
Highest
Price Target
82.95 USD
136% Upside
IDEAYA Biosciences Inc Competitors:
Price Targets
ACLX
Arcellx Inc
76% Upside
NGNE
Neurogene Inc
201% Upside
ACAD
ACADIA Pharmaceuticals Inc
8% Upside
OPK
OPKO Health Inc
190% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
35% Upside
ABNX
Abionyx Pharma SA
213% Upside
ANAB
AnaptysBio Inc
16% Upside
ZYME
Zymeworks Inc
35% Upside

Revenue
Forecast

Revenue Estimate
IDEAYA Biosciences Inc

The compound annual growth rate of IDEAYA Biosciences Inc's revenue for the next 4 years is 140%.

N/A
Past Growth
140%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
IDEAYA Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
IDEAYA Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IDYA's stock price target?
Price Target
50.62 USD

According to Wall Street analysts, the average 1-year price target for IDYA is 50.62 USD with a low forecast of 31.31 USD and a high forecast of 82.95 USD.

What is IDEAYA Biosciences Inc's Revenue forecast?
Projected CAGR
140%

The compound annual growth rate of IDEAYA Biosciences Inc's revenue for the next 4 years is 140%.

Back to Top